Most people with high blood pressure can safely take GLP-1 medications
Both medications are life-changing for those struggling with obesity, diabetes, and metabolic issues
In a randomized controlled trial, rifaximin attenuates gut-derived systemic inflammation by suppressing oralization-associated, mucin-degrading sialidase-rich species (e.g., Streptococcus and Veillonella ) and promoting a barrier-repairing intestinal environment [126]
Furthermore, it is also difficult to make conclusions about the causal relationships because there might be confounders such as the severity of DM and the occurrence of pancreatic cancers, among others
Its not fully understood why, but Dr Lofton suggests it could be that the brain is sending a sweet craving instead of a hunger signal
Canadians could get more affordable version of Ozempic in early 2026